RJA
GMED icon

Raymond James & Associates’s Globus Medical GMED Stock Holding History

Raymond James & Associates’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$21.4M Buy
299,294
+23,349
+8% +$1.65M 0.01% 781
2024
Q2 		$18.9M Buy
275,945
+35,402
+15% +$2.12M 0.01% 809
2024
Q1 		$12.9M Buy
240,543
+37,671
+19% +$2.03M 0.01% 1018
2023
Q4 		$10.8M Sell
202,872
-229,909
-53% -$11.2M 0.01% 1061
2023
Q3 		$21.5M Buy
432,781
+83,648
+24% +$4.68M 0.02% 647
2023
Q2 		$20.8M Buy
349,133
+72,442
+26% +$4.13M 0.02% 669
2023
Q1 		$15.7M Sell
276,691
-335,614
-55% -$21.5M 0.01% 797
2022
Q4 		$45.5M Buy
612,305
+181,254
+42% +$12.3M 0.04% 376
2022
Q3 		$25.7M Buy
431,051
+210,142
+95% +$12.7M 0.03% 518
2022
Q2 		$12.4M Buy
220,909
+52,267
+31% +$3.44M 0.01% 853
2022
Q1 		$12.4M Buy
168,642
+3,068
+2% +$213K 0.01% 958
2021
Q4 		$12M Buy
165,574
+1,805
+1% +$131K 0.01% 997
2021
Q3 		$12.5M Sell
163,769
-3,048
-2% -$245K 0.01% 938
2021
Q2 		$12.9M Sell
166,817
-14,281
-8% -$1.02M 0.01% 932
2021
Q1 		$11.2M Sell
181,098
-49,709
-22% -$3.15M 0.01% 967
2020
Q4 		$15.1M Sell
230,807
-33,760
-13% -$1.94M 0.02% 740
2020
Q3 		$13.1M Buy
264,567
+44,538
+20% +$2.3M 0.02% 725
2020
Q2 		$10.5M Buy
220,029
+41,393
+23% +$2M 0.01% 806
2020
Q1 		$7.6M Buy
178,636
+99,958
+127% +$4.94M 0.01% 850
2019
Q4 		$4.63M Sell
78,678
-6,128
-7% -$333K 0.01% 1306
2019
Q3 		$4.33M Buy
84,806
+37,816
+80% +$1.8M 0.01% 1310
2019
Q2 		$1.99M Buy
46,990
+23,629
+101% +$1.03M ﹤0.01% 1804
2019
Q1 		$1.15M Buy
23,361
+8,887
+61% +$402K ﹤0.01% 2118
2018
Q4 		$626K Buy
14,474
+2,887
+25% +$144K ﹤0.01% 2392
2018
Q3 		$658K Buy
11,587
+724
+7% +$38.1K ﹤0.01% 2517
2018
Q2 		$548K Buy
10,863
+3,730
+52% +$195K ﹤0.01% 2617
2018
Q1 		$355K Sell
7,133
-13,214
-65% -$621K ﹤0.01% 2783
2017
Q4 		$836K Sell
20,347
-43,073
-68% -$1.51M ﹤0.01% 2225
2017
Q3 		$1.89M Buy
63,420
+1,592
+3% +$48.6K ﹤0.01% 1685
2017
Q2 		$2.05M Buy
61,828
+5,940
+11% +$187K ﹤0.01% 1559
2017
Q1 		$1.66M Buy
55,888
+266
+0.5% +$7.26K ﹤0.01% 1652
2016
Q4 		$1.38M Buy
55,622
+475
+0.9% +$10.8K ﹤0.01% 1737
2016
Q3 		$1.25M Sell
55,147
-1,128
-2% -$26.5K ﹤0.01% 1747
2016
Q2 		$1.34M Sell
56,275
-709
-1% -$17K ﹤0.01% 1566
2016
Q1 		$1.35M Buy
56,984
+1,342
+2% +$32.8K ﹤0.01% 1504
2015
Q4 		$1.55M Sell
55,642
-7,725
-12% -$194K 0.01% 1400
2015
Q3 		$1.31M Buy
63,367
+840
+1% +$21.3K 0.01% 1449
2015
Q2 		$1.6M Sell
62,527
-93,705
-60% -$2.37M 0.01% 1451
2015
Q1 		$3.94M Buy
156,232
+86,856
+125% +$2.12M 0.02% 866
2014
Q4 		$1.65M Buy
+69,376
New +$1.54M 0.01% 1274

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
HRCM
Hawk Ridge Capital Management Los Angeles, California $2.75B AUM 20.09% 1-Year Est. Return

Raymond James & Associates's GMED Position: Q3 2024 in Review

Raymond James & Associates increased its Globus Medical (GMED) stake by 8.5% in Q3 2024, buying an estimated $1.65M and bringing the position to 299,294 shares worth $21.4M. The position accounts for 0.01% of the portfolio, ranked #781.

Raymond James & Associates first reported a position in GMED in Q4 2014 and has held it in 40 quarters since. The position peaked at $45.5M in Q4 2022. 449 funds tracked by Wall St. Rank hold GMED as of Q3 2024.

  • Raymond James & Associates held 299,294 shares of Globus Medical worth $21.4M as of Q3 2024.
  • Raymond James & Associates bought 23,349 Globus Medical shares in Q3 2024, an estimated $1.65M.
  • Globus Medical made up 0.01% of Raymond James & Associates's portfolio in Q3 2024, its #781 holding.
  • Raymond James & Associates first reported a position in Globus Medical in Q4 2014 and has held it in 40 quarters since.
  • Raymond James & Associates's Globus Medical position peaked at $45.5M in Q4 2022.
  • 449 funds tracked by Wall St. Rank held Globus Medical as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.